Why Clinical AI Demands a Dedicated Risk Framework
Artificial intelligence is no longer a future-state consideration for health systems—it is embedded in radiology workflows, sepsis prediction engines, revenue cycle operations, and clinical decision support tools used at the point of care today. Yet most health system risk management programs were designed around traditional IT assets: servers, endpoints, network segments, and structured databases. AI introduces a fundamentally different risk profile. Models can drift, training data can embed bias, and opaque decision logic can undermine clinician trust and patient safety in ways that conventional vulnerability management cannot address.
Released in January 2023, the NIST Artificial Intelligence Risk Management Framework (AI RMF 1.0) offers the most comprehensive, voluntary governance structure available for organizations deploying AI systems. For healthcare CISOs, compliance officers, and clinical informatics leaders, the challenge is not whether to adopt the framework—it is how to operationalize it within the complex regulatory environment defined by HIPAA, FDA software-as-a-medical-device (SaMD) guidance, and emerging state-level AI transparency laws.
Understanding the NIST AI RMF Core Structure
The NIST AI RMF is organized around four core functions: Govern, Map, Measure, and Manage. Each function contains categories and subcategories that guide organizations toward trustworthy AI. Unlike the NIST Cybersecurity Framework (CSF), which focuses on protecting information systems, the AI RMF explicitly addresses characteristics such as fairness, explainability, reliability, safety, and accountability—dimensions that carry outsized consequences in clinical settings.
Govern: Establishing AI Accountability in the C-Suite
The Govern function calls for organizational policies, processes, and structures that foster a culture of responsible AI use. In healthcare, this means creating a cross-functional AI Governance Committee that includes representation from information security, clinical leadership, legal/compliance, data science, and bioethics. This body should own the AI risk appetite statement, approve model deployment decisions, and maintain an authoritative inventory of all AI systems in production—including third-party vendor models embedded in EHR modules or diagnostic platforms.
Actionable step: Extend your existing HITRUST CSF or NIST CSF governance documentation to include AI-specific policies. Define roles explicitly—who is the "model owner" responsible for ongoing performance? Who triggers a risk reassessment when a vendor updates a model?
Map: Contextualizing AI Risk in Clinical Workflows
Mapping requires organizations to understand the context in which an AI system operates, including its intended use, the stakeholders impacted, and the potential harms of failure. In clinical AI, this means conducting a thorough clinical workflow impact analysis for each model. A sepsis prediction algorithm deployed in an ICU carries different risk characteristics than an AI-powered scheduling optimizer, even if both process PHI.
Actionable step: For each clinical AI deployment, document the intended clinical population, the decision the model informs, the human-in-the-loop controls, and the failure modes. Map these to HIPAA Security Rule requirements (§164.308 administrative safeguards) and, where applicable, FDA pre-market or post-market surveillance expectations for SaMD.
Measure: Quantifying Bias, Drift, and Performance Degradation
The Measure function focuses on employing quantitative and qualitative techniques to assess AI risks. Health systems should establish continuous model monitoring that tracks performance metrics stratified by demographic subgroups—race, age, sex, and socioeconomic proxies—to detect disparate impact. Model drift detection is equally critical: a diagnostic model trained on pre-pandemic imaging data may perform poorly on post-COVID patient populations without recalibration.
Actionable step: Integrate model performance monitoring into your existing security operations or clinical analytics dashboards. Define thresholds that trigger automatic alerts—for example, a greater than 5% degradation in sensitivity for any demographic subgroup over a rolling 90-day window. Document these metrics as evidence for HITRUST assessments and OCR compliance audits.
Manage: Responding to AI Incidents Before They Become Patient Safety Events
The Manage function addresses the prioritization and response to identified AI risks. Health systems should develop an AI-specific incident response playbook that complements their existing IR plan. This playbook should address scenarios such as: a model producing clinically dangerous recommendations, discovery of biased outputs affecting a protected population, adversarial manipulation of model inputs, and vendor-initiated model updates that alter clinical behavior without adequate validation.
Actionable step: Conduct tabletop exercises at least annually that simulate an AI failure in a clinical context. Include clinicians, data scientists, and legal counsel. Document findings and remediation timelines using the same rigor you apply to HIPAA breach response procedures.
Bridging the AI RMF with Existing Healthcare Compliance Frameworks
One of the most practical strategies for healthcare organizations is to crosswalk the NIST AI RMF with frameworks already in use. HITRUST CSF v11 has begun incorporating AI-related control considerations. The NIST CSF 2.0, released in February 2024, now includes a Govern function that aligns naturally with the AI RMF's governance requirements. Additionally, the HHS Office for Civil Rights has signaled increased scrutiny of AI systems that process PHI, particularly regarding algorithmic fairness under Section 1557 of the ACA.
For organizations pursuing HITRUST r2 certification, mapping AI RMF subcategories to relevant HITRUST control domains—such as Risk Management (03.0), Third-Party Assurance (05.0), and Information Protection (09.0)—creates an efficient, audit-ready documentation structure that satisfies multiple compliance obligations simultaneously.
Moving Forward: Building AI Risk Maturity
Clinical AI governance is not a checkbox exercise. It is an evolving discipline that requires health systems to invest in cross-functional expertise, continuous monitoring infrastructure, and a willingness to slow or halt AI deployments when risk thresholds are exceeded. The NIST AI RMF provides an excellent scaffolding, but its value depends entirely on execution. Start with your highest-risk clinical AI systems, build repeatable processes, and integrate AI risk management into your broader enterprise risk program. The organizations that do this well will not only protect patients—they will earn the trust necessary to scale AI innovation responsibly.